GSK: Artemis-8 Phase III Study Meets Primary Endpoint In Advanced Or Relapsed Small-Cell Lung Cancer
GSK: Artemis-8 Phase III Study Meets Primary Endpoint In Advanced Or Relapsed Small-Cell Lung Cancer
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.